MIC Electronics LtdMICEL

Filings that matter

• 2
  GeneralNeutral

  Biopol Chemicals Limited disclosed a substantial acquisition of shares and related transactions. - The company is complying with SEBI regulations for such acquisitions. Impact: 2/10 · Neutral

  Source PDF →
• 1
  ComplianceNeutral

  Financial statements for the fiscal year ending March 2025 have been revised. • The revision could indicate potential changes in financial performance or disclosures. Impact: 1/10 · Neutral

• 1
  ESG / BRSRNeutral

  ESG/BRSR Report Submitted Impact: 1/10 · Neutral

• 1
  ComplianceNeutral

  Financial statements revised for the fiscal year ending March 2026. • No specific financial impacts or changes mentioned. Impact: 1/10 · Neutral

• 1
  ComplianceNeutral

  Financial statements for the fiscal year ending March 2025 have been revised. • The revision could indicate potential changes in financial performance or disclosures. Impact: 1/10 · Neutral

• 2
  Annual reportNeutral

  Revenue growth slowed to 8.83% in FY 2025-26 compared to previous years. - EBITDA margin remained stable at 18.54%, indicating consistent operational efficiency. Impact: 2/10 · Neutral

  Source PDF →
• 1
  ESG / BRSRNeutral

  ESG/BRSR report submitted. Impact: 1/10 · Neutral

• 1
  ComplianceNeutral

  Financial statements revised for the fiscal year ending March 2026. • No specific financial impacts mentioned. Impact: 1/10 · Neutral

• 3
  GeneralNeutral

  Sanginita Chemicals Limited received transfer of 9,500,000 equity shares from B N G Investment LLC. - This marks a step in the acquisition of 100% stake in Agastya Green Energy Limited. Impact: 3/10 · Neutral

  Source PDF →
• 1
  ComplianceNeutral

  Financial statements revised for the fiscal year ending March 2026. • No specific financial impacts or changes mentioned. Impact: 1/10 · Neutral

• 2
  GeneralNeutral

  Sanginita Chemicals Limited announced an alteration of capital structure. - The company is raising funds through the allotment of securities. Impact: 2/10 · Neutral

• 2
  Annual reportNeutral

  Revenue growth for FY 2025-26 was 8.83%, slightly down from the previous year. - EBITDA margin improved to 18.54% compared to 19.14% in the prior fiscal. Impact: 2/10 · Neutral

  Source PDF →

Bulk & block deals

Results & transcripts